Viking Therapeutics (VKTX) Tops Q3 EPS by 4c
Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.